First CAR T-Cell Therapies OK'd In EU: Novartis's Kymriah And Kite's Yescarta

 
• By Ian Schofield and Neena Brizmohun
  
Recommended
The CHMP has recommended nine products for marketing authorization in the EU
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews